Alimentary Health Expertise

AH believes that an understanding of the interactions between human gut flora (probiotics) and the human immune system will lead to the development of a new generation of natural, safe treatments for major diseases. It is now believed that human health and well-being are based on a condition of "homeostasis", or an equilibrium between the numerous systems in the body that control the range of bodily functions and the environment, be it internal, in the gut, or external.

It has been suggested that this state of homeostasis is, in part, a result of the co-evolution of the host immune system and its gastrointestinal flora over millions of years. This provides for a tantalising and exciting scientific rationale that the gut flora is a potential repository of therapeutic bio-actives for a number of major disease conditions.

AH’s research programme is designed to investigate and deliver on this potential.

The strength of AH’s scientific programme and focus on research has enabled the company to broaden its GI franchise and pursue other indications associated with the basic mechanisms of action of its technology. For example, some preclinical evidence for symptom reduction in animal models of arthritis suggests that there may also be therapeutic benefit from AH technology in systemic inflammatory conditions as well as in the gastrointestinal tract.